( NASDAQ-NMS:AMRI )

News from amri A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

08:00 ET AMRI CEO to Present at Baird 2016 Global Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will...


Aug 23, 2016, 16:05 ET AMRI Licenses CRISPR-Cas9 Gene Editing Technology

 AMRI (NASDAQ: AMRI) today announced that it entered into a non-exclusive commercial license agreement with the Broad Institute of MIT and...


Aug 04, 2016, 07:30 ET AMRI Announces Second Quarter 2016 Results

 AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2016 and provided an update to its...


Jul 15, 2016, 08:00 ET AMRI to Announce Second Quarter 2016 Results

AMRI (NASDAQ: AMRI) today announced it will issue second quarter 2016 financial results before the opening of the market on Thursday, August 4,...


Jul 11, 2016, 07:25 ET AMRI Completes Acquisition of Euticals

 AMRI (NASDAQ: AMRI) today announced that it has completed the acquisition of Prime European Therapeuticals S.p.A., also known as "Euticals", a...


Jun 22, 2016, 08:00 ET Teewinot Life Sciences Corporation Licenses Biosynthetic Technology to AMRI for the Production and Sale of the First Commercially Available CBCA Analytical Standard

 Teewinot Life Sciences Corporation (Teewinot) and Albany Molecular Research, Inc. (NASDAQ: AMRI) today announced that AMRI has licensed...


Jun 14, 2016, 08:05 ET AMRI Selected as a Dedicated Chemical Biology Consortium Center to Expand Drug Development

 AMRI (NASDAQ: AMRI) today announced that its Buffalo, N.Y. site has been selected to participate as a Dedicated Chemical Biology...


May 23, 2016, 08:00 ET AMRI CEO to Present at Jefferies 2016 Healthcare Conference

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will...


May 10, 2016, 10:28 ET AMRI Clarifies 2016 Revenue Guidance

AMRI (NASDAQ: AMRI) clarified its 2016 revenue guidance, following the company's first quarter earnings conference call held earlier this...


May 10, 2016, 07:35 ET AMRI Announces First Quarter 2016 Results

 AMRI (NASDAQ: AMRI) today reported financial and operating results for the first quarter ended March 31, 2016 and provided an update to its...


May 05, 2016, 07:33 ET AMRI to Acquire Euticals in a Strategic Transaction That Expands its API Development and Manufacturing Business

- Enters definitive agreement to acquire Euticals for $358 million in stock, cash and a seller note - Positions AMRI as one of the...


Apr 28, 2016, 07:00 ET AMRI to Announce First Quarter 2016 Results

 AMRI (NASDAQ: AMRI) today announced it will issue first quarter 2016 financial results before the opening of the market on Tuesday, May 10,...


Mar 30, 2016, 07:11 ET AMRI Announces Filing of Annual Report on Form 10K

AMRI (NASDAQ: AMRI) today announced that it has filed with the U.S. Securities and Exchange Commission (SEC) its Annual Report on Form 10-K for the...


Mar 14, 2016, 08:00 ET AMRI Wins Four Life Science Leader Awards

 AMRI (NASDAQ: AMRI) today announced that it has been recognized as a Life Science Leader CMO Leadership Award recipient in the categories of...


Mar 11, 2016, 16:47 ET AMRI Announces Extension to File Form 10K for 2015

AMRI (NASDAQ: AMRI) today announced that it has filed with the U.S. Securities and Exchange Commission (SEC) a Form 12b-25 Notification of Late...


Feb 17, 2016, 07:30 ET AMRI Announces Fourth Quarter and Full Year 2015 Results and Provides 2016 Outlook

AMRI (NASDAQ: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2015 and provided an...


Feb 17, 2016, 07:15 ET AMRI Appoints David H. Deming and Kenneth P. Hagen to Board of Directors

 AMRI (NASDAQ: AMRI) today announced the appointment of David H. Deming, Managing Partner, TAG Healthcare Advisors, and Kenneth P. Hagen,...


Feb 09, 2016, 08:00 ET AMRI to Announce Fourth Quarter and Full Year 2015 Results

 AMRI (NASDAQ: AMRI) today announced it will issue fourth quarter and full year 2015 financial results before the opening of the market on...


Feb 04, 2016, 16:05 ET AMRI Appoints Anthony J. Maddaluna to Board of Directors

 AMRI (NASDAQ: AMRI) today announced that Anthony J. Maddaluna, Executive Vice President of Pfizer Inc. and President of Pfizer Global...


Jan 20, 2016, 08:45 ET AMRI Announces Executive Hire to Lead Active Pharmaceutical Ingredients Business

 AMRI (NASDAQ: AMRI) announced today that Dawn M. Von Rohr, will join AMRI as Sr. Vice President, API, effective January 25, 2016....


Jan 14, 2016, 08:00 ET AMRI and NYCNMR Form Collaborative Agreement

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that it has signed a collaboration agreement with the New York Center for...


Jan 12, 2016, 07:00 ET AMRI Announces 3-Year Extension of Insourcing Contract

 AMRI (NASDAQ: AMRI) is pleased to announce the extension of a key insourcing relationship with a major pharmaceutical company designed to...


Jan 11, 2016, 06:45 ET AMRI Announces First Product Approval Out of its Massachusetts Aseptic Fill Finish Site

 AMRI (NASDAQ: AMRI) announced that Docetaxel Injection (non-alcohol formula) has been approved for commercial manufacture at its Burlington,...


Jan 10, 2016, 18:00 ET AMRI Date and Time Change for J.P. Morgan Healthcare Conference Presentation

 Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will...


Jan 07, 2016, 11:03 ET AMRI and Icagen Ink Collaboration Agreement

 Albany Molecular Research Inc. (NASDAQ: AMRI) and Icagen, Inc. announced today that they have signed a collaboration agreement to co-market...